
SEMAGLUTIDE 1 mg/0.5 mL (Noveltreat) Injectable Solution is a prescription once-weekly GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes. It may also help reduce appetite, support weight management, and lower the risk of certain cardiovascular events in eligible patients when used alongside a healthy diet and regular exercise.
| Generic name | SEMAGLUTIDE |
| Strength | 1 mg |
| Manufacturer | Sun Pharmaceutical |
| Package size | 2 Single Dose Prefilled Pens of 1 mg/0.5 ml |
| Used for | Type 2 diabetes and chronic weight management |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Semaglutide 1 mg works by mimicking the action of glucagon-like peptide-1 (GLP-1), a natural hormone that increases insulin release when blood sugar levels are high. It also reduces glucagon secretion, slows stomach emptying, and decreases appetite. These combined effects help improve blood sugar control and support weight management.